Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 2,761

Document Document Title
WO/2016/194809A1
Provided is a Siraitia grosvenorii extract preparation method, whereby it becomes possible to remove an agrochemical selectively and efficiently from a Siraitia grosvenorii extract containing the agrochemical and to collect a Siraitia gr...  
WO/2016/189200A1
Method of recovering sterols from tall oil pitch which contains steryl esters. In the method the tall oil pitch is subjected to a transefterification reaction with a lower alcohol in a reaction zone to provide a reaction product mixture ...  
WO/2016/190480A1
The present invention relates to: a method for screening a mitochondrial fission controlling agent using a cell treated with a protopanaxadiol (PPD) ginsenocide compound; a composition for screening a mitochondrial fission controlling ag...  
WO/2016/173397A1
The present invention relates to a cholic acid derivative, and a preparation method and a medical use thereof. In particular, the present invention relates to a cholic acid derivative with the structure of formula (I), a stereoisomer, or...  
WO/2016/173524A1
Disclosed in the present application are the compounds as shown in formulae I, II, III, IV or V, tautomers thereof, stereoisomers thereof or pharmaceutically acceptable salts thereof, and also disclosed is the use thereof in preparing dr...  
WO/2016/176208A1
The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions.  
WO/2016/172553A1
Disclosed herein are methods of making ceragnenin compounds for treating, preventing, or diagnosing diseases, disorders, or conditions associated with bacterial or viral infections, cancer, inflammation, and osteogenesis. Ceragenin compo...  
WO/2016/165496A1
Disclosed is method for preparing a deoxycholic acid or ester thereof or pharmaceutically acceptable salt thereof. The compound is suitable for removing fat deposition.  
WO/2016/164413A1
The present application relates to a pharmaceutical composition comprising a combination of an FXR agonist and at least one additional therapeutic agent that lowers the glucose level in the blood, stimulates insulin secretion, and/or inc...  
WO/2016/142922A1
The invention relates to compounds of formula (I), to the pharmaceutical compositions comprising same, and to the use thereof in the treatment of bacterial, fungal, viral and parasitic infections or in the treatment of cancer in humans o...  
WO/2016/144946A1
The present invention relates to methods of treating, reducing the risk of, preventing, or alleviating a symptom of a disease or condition associated with changes in bone density, osteoporosis, or an osteopenic disease, or inducing osteo...  
WO/2016/137196A1
The present invention relates to a fatty acid-conjugated 7-dehydrocholesterol derivative and a composition for reducing wrinkles and preventing aging containing the same. The fatty acid-conjugated 7-dehydrocholesterol derivative accordin...  
WO/2016/131414A1
The present invention relates to a deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising the compound thereof. Specifically, disclosed are a deuterated chenodeoxycholic acid derivative represented by formu...  
WO/2016/123028A1
The present disclosure provides compounds that include a tetrazolone derivative of a carboxyl group of an active agent. This disclosure also relates to pharmaceutical compositions that include these compounds, methods of using these comp...  
WO/2016/107471A1
The present invention relates to a chemical and pharmaceutical technology, and in particular to a STAT3 and ERK signal pathway inhibitor and a use thereof. On the one hand, provided is a STAT3 and ERK signal pathway inhibitor. The inhibi...  
WO/2016/107575A1
The present invention relates to a crystal form A of obeticholic acid and a preparation method therefor. The crystal form A provided by the present invention has characteristic peaks at 2theta having values of 4.9º±0.2º, 5.2º±0.2º ...  
WO/2016/096988A1
The present invention relates to method of extracting cholesterol from milk fat.  
WO/2016/086115A1
The present invention provides compounds of Formula I: pharmaceutical compositions comprising these compounds and methods of using these compounds to treat or prevent a disease or disorder mediated by FXR and/or TGR5.  
WO/2016/079520A1
The invention relates to compounds of formula (I), wherein R1, R2, Y, R4 and R5b are as defined herein. The compounds are intermediates in the synthesis of synthetic bile acids.  
WO/2016/079518A1
The invention relates to compounds of formula (I): wherein R1, R2, Y, R4 and R5 are as defined herein. The compounds are intermediates in the synthesis of synthetic bile acids.  
WO/2016/079517A1
The invention relates to compounds of formula (I), wherein R1, R2, Y, R4 and R5 are as defined herein. The compounds are intermediates in the synthesis of synthetic bile acids.  
WO/2016/060276A1
The purpose of the present invention is to provide: a mogrol glycosyltransferase; and a method for producing a mogrol glycoside using the enzyme. The present invention provides: a mogrol glycosyltransferase; and a method for producing a ...  
WO/2016/045642A1
The invention provides for treating HBV or HDV infection or inhibiting human sodium taurocholate co-transporting polypeptide (hNTCP) with a polymeric bile acid or salt thereof, and pharmaceutical compositions comprising a polymeric bile ...  
WO/2016/045480A1
Provided are a compound represented by formula (III) and a preparation method therefor, wherein R1 is a hydroxyl protective group and preferably is MOM; and also provided is a method for preparing obeticholic acid by using the compound. ...  
WO/2016/029888A1
The present invention provides amphiphilic compounds with tetradecahydrophenanthrene skeleton and their enantiomers, exhibiting neuroprotective effects, their use as medicaments for treating neuropsychiatric disorders associated with an ...  
WO/2016/029197A1
The disclosure generally relates to compositions and uses thereof to treat vision disorders that affect the normal function of the lens in the eye in a subject having or at risk of developing such vision disorders.  
WO/2016/023082A1
H:\dar\Interwoven\NRPortbl\DCC\DAR\8230712_1.doc-12/08/2015 Abstract The present invention relates to compounds and their uses, in particular, compounds in the form of prodrugs that promote transport of a pharmaceutical agent to the lymp...  
WO/2016/015512A1
Disclosed is a method for synthesizing 25-hydroxy cholesterol. The method is as below: subjecting 24-dehydrocholesterol derivative as a raw material and a hydroxyl containing reagent to an addition reaction in the presence of a catalyst ...  
WO/2015/195967A1
Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein X, Y, R1, R2a, R2b, R4a, R4b, R5a, R5b, R6a, R6b, R7, and R8 are as defined herein. Compounds...  
WO/2015/195962A1
Described herein are steroids of Formula (I): and pharmaceutically acceptable salts thereof; wherein R1, R2a, R2b, R3, R4, R5a, R5b, R6, and Z are as defined herein. Such compounds are contemplated useful for the prevention and treatment...  
WO/2015/184668A1
The present invention provides an ergosterol compound, a preparation method therefor, and an application thereof. A molecular formula of the ergosterol compound is C28H44O, a molecular weight is 396.34, and a molecular structure is: (3R,...  
WO/2015/181275A1
13073PTWO 56 ABSTRACT The present invention relates to compounds having cholane scaffolds of formula (I), said compounds for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases. 5  
WO/2015/170341A1
The invention discloses an improved cost-effective process for preparation of 7-Dehydrocholesterol of formula I with good yield and purity, comprising:a) epimerizing 7(alpha+beta) bromo protected cholesterol in presence of tetrabutyl amm...  
WO/2015/168636A1
Oxysterol-bisphosphonate and oxysterol-alendronic acid compounds, compositions including them, and methods using them for the treatment of bone disorders.  
WO/2015/158163A1
The present invention relates to cyclopentanoperhydrophenanthrene framework compounds and a preparation method therefor. The compounds have certain biological activity, can also be used as an intermediate synthon for synthesizing some co...  
WO/2015/137289A1
The present invention pertains to spherical water-dispersible amorphous particles having a particle diameter of 10-990 nm and a PDI of 0.01-0.5, wherein the amorphous particles contain an organic compound having a molecular weight of 50-...  
WO/2015/135927A1
The invention relates to 2,4,6-octatrienoic acid derivative compounds having general formula (I) (CH3-CH=CH-CH=CH-CH=CH-CO-O-)n-R (I) consisting of esters wherein n = 1, 2, 3 and wherein R is selected from alkyl, aryl or cycloalkyl of a ...  
WO/2015/115796A1
The present invention relates to a PEGylated 7-dehydrocholesterol derivative, and a composition for wrinkle alleviation and antiaging, containing the same. The PEGylated 7-dehydrocholesterol derivative, according to the present invention...  
WO/2015/116867A1
Provided are labeling reagents and methods of using the reagents for cell uptake measurements. The labeling reagents can be quinone- masked probes including fluorophores and/or luminophores.  
WO/2015/101468A1
The present invention relates to a broad spectrum stable sunscreen molecule having the general structure (Formula) where "X" is an organic sunscreen belonging to the UVA class and "Y" is an organic sunscreen belonging to UVB class or vic...  
WO/2015/057047A9
The invention relates to a method for the enzymatic synthesis of lithocholic acid oleate and for the efficient purification of same. The lithocholic acid oleate is a molecule that serves as an antimicrobial peptide elicitor and has an in...  
WO/2015/076788A1
The present invention relates to pharmaceutical compositions containing muricholic acid-based compounds, as well as methods of treatment, and methods of screening that use these compounds and compositions.  
WO/2015/049657A1
The object of the present invention is a new anhydrous polymorphic crystalline form of sodium hyodeoxycholate (NaHDC) named as form II (FII) and the process for preparing it. Such a process makes it possible to obtain sodium hyodeoxychol...  
WO/2015/034010A1
The present invention was completed based on the finding that a compound represented by general formula (I) [wherein R1 and R2 independently represent a hydrocarbon group having 1-5 carbon atoms] or a pharmaceutically acceptable salt the...  
WO/2015/019358A1
The present invention provides topical compositions comprising fatty acid bile acid conjugates (FABACs). The present invention further provides methods of using the disclosed compositions for preventing, attenuating or treating skin agin...  
WO/2015/017813A2
Disclosed are inhibitors of the farnesoid X receptor, for example of formula (I), wherein R1, R2, R4, X, Y, Z, m, and n are as defined herein, which are useful in treating or preventing obesity, type 2 diabetes/insulin resistance and non...  
WO/2014/198992A1
Bioinspired antifungal systems. The invention relates to novel systems based on substrates containing covalently bonded ergosterol molecules that can comprise antifungal compounds imitating the joining of the antifungal agent to the wall...  
WO/2014/195950A1
Compositions and methods for treating diseases or disorders associated with the metabolic syndrome using conjugates of bile acids with basic amino acids or a decarboxylated amino acid such as agmatine are provided. Further provided are b...  
WO/2014/184271A1
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, wherein R1 is a hydroxy group and R2, R3, R4, R5, and R6 are as described herein. The present inven...  
WO/2014/183550A1
Provided in the present invention are a phosphatidyl sterol and/or phosphatidyl stanol rich in polyunsaturated fatty acyls and the preparation method thereof, which are mainly for solving the following technical problems: poor solubility...  

Matches 251 - 300 out of 2,761